المؤلفون: Degaga A, Sirgu S, Huri HZ, Sim MS, Loganadan NK, Kebede T, Tegene B, Engidawork E, Shibeshi W

المصدر: Pharmacogenomics and Personalized Medicine, Vol Volume 17, Pp 183-191 (2024)

مصطلحات موضوعية: metformin intolerance, slc22a1 gene, rs72552763, ethiopia, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/association-of-the-reduced-function-met420del-polymorphism-of-slc22a1--peer-reviewed-fulltext-article-PGPM; https://doaj.org/toc/1178-7066

URL الوصول: https://doaj.org/article/c232e842eda448b2af046239168273e5

المؤلفون: Sim R, Chong CW, Loganadan NK, Hussein Z, Adam NL, Lee SWH

المصدر: Patient Preference and Adherence, Vol Volume 17, Pp 2109-2117 (2023)

مصطلحات موضوعية: diabetes, covid-19, sars-cov 2, adherence, weight, glycemic, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/impact-of-covid-19-lockdown-on-glycemic-weight-blood-pressure-control--peer-reviewed-fulltext-article-PPA; https://doaj.org/toc/1177-889X

URL الوصول: https://doaj.org/article/0945f713fc9d47358c52e0dec758a382

المؤلفون: Degaga A, Sirgu S, Huri HZ, Sim MS, Kebede T, Tegene B, Loganadan NK, Engidawork E, Shibeshi W

المصدر: Diabetes, Metabolic Syndrome and Obesity, Vol Volume 16, Pp 2523-2535 (2023)

مصطلحات موضوعية: t2dm, glycemic response, metformin, slc22a1 gene, met420del, ethiopia, Specialties of internal medicine, RC581-951

وصف الملف: electronic resource

Relation: https://www.dovepress.com/association-of-met420del-variant-of-metformin-transporter-gene-slc22a1-peer-reviewed-fulltext-article-DMSO; https://doaj.org/toc/1178-7007

URL الوصول: https://doaj.org/article/ea5e024063454a7d8ffa56ef41357531

المؤلفون: Sim R; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia., Chong CW; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia., Loganadan NK; Department of Pharmacy, Putrajaya Hospital, Ministry of Health Malaysia, Putrajaya, Malaysia., Saidoung P; Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA., Adam NL; Hospital Tuanku Jaafar, Ministry of Health Malaysia, Seremban Malaysia., Hussein Z; Department of Medicine, Putrajaya Hospital, Ministry of Health Malaysia, Putrajaya, Malaysia., Chaiyakunapruk N; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA., Lee SWH; School of Pharmacy, Monash University Malaysia, Selangor, Malaysia; School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Selangor, Malaysia; Asian Centre for Evidence Synthesis in Population, Implementation and Clinical Outcomes (PICO), Health and Well-being Cluster, Global Asia in the 21st Century (GA21) Platform, Monash University Malaysia, Selangor, Malaysia; Center for Global Health, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: shaun.lee@monash.edu.

المصدر: Value in health regional issues [Value Health Reg Issues] 2023 Nov; Vol. 38, pp. 9-17. Date of Electronic Publication: 2023 Jul 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2* , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use, Humans ; Cost-Benefit Analysis ; Glucose/therapeutic use ; Malaysia

المؤلفون: Ng YK; Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia., Shah NM; Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia., Chen TF; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, NSW 2006, Australia., Loganadan NK; Department of Pharmacy, Hospital Putrajaya, Ministry of Health, Pusat Pentadbiran Kerajaan Persekutuan Presint 7, 62250 Putrajaya, Malaysia., Kong SH; Department of Pharmacy, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur, Malaysia., Cheng YY; Department of Pharmacy, Hospital Ampang, Ministry of Health, Jalan Mewah Utara, Taman Pandan Mewah, 68000 Ampang Jaya, Selangor, Malaysia., Sharifudin SSM; Department of Pharmacy, Hospital Kuala Lumpur, Ministry of Health, Jalan Pahang 50586, Kuala Lumpur, Malaysia., Chong WW; Centre of Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

المصدر: Exploratory research in clinical and social pharmacy [Explor Res Clin Soc Pharm] 2023 Aug 26; Vol. 11, pp. 100325. Date of Electronic Publication: 2023 Aug 26 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918266300706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-2766 (Electronic) Linking ISSN: 26672766 NLM ISO Abbreviation: Explor Res Clin Soc Pharm Subsets: PubMed not MEDLINE

المؤلفون: Sim R; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia., Chong CW; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia., Loganadan NK; Department of Pharmacy, Putrajaya Hospital, Ministry of Health Malaysia, Jalan P9, Presint 7, Putrajaya, Wilayah Persekutuan Putrajaya, Malaysia., Adam NL; Department of Medicine, Hospital Tuanku Jaafar, Ministry of Health Malaysia, Jalan Rasah, Bukit Rasah, Seremban, Negeri Sembilan, Malaysia., Hussein Z; Department of Medicine, Putrajaya Hospital, Ministry of Health Malaysia, Jalan P9, Presint 7, Putrajaya, Wilayah Persekutuan Putrajaya, Malaysia., Lee SWH; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia.; School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, 1, Jln Taylors, Subang Jaya, Selangor, Selangor, Malaysia.; Asian Centre for Evidence Synthesis in Population, Implementation and Clinical Outcomes (PICO), Health and Well-being Cluster, Global Asia in the 21st Century (GA21) Platform, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia.; Center for Global Health, University of Pennsylvania, Philadelphia, PA, USA.

المصدر: Clinical kidney journal [Clin Kidney J] 2022 Dec 07; Vol. 16 (3), pp. 549-559. Date of Electronic Publication: 2022 Dec 07 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN: 2048-8505 (Print) Linking ISSN: 20488505 NLM ISO Abbreviation: Clin Kidney J Subsets: PubMed not MEDLINE

المؤلفون: Sim, R, Chong, CW, Loganadan, NK, Adam, NL, Hussein, Z, Lee, SWH

المصدر: In Value in Health December 2022 25(12) Supplement:S58-S58

المؤلفون: Sim R; School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia., Chong CW; School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia., Loganadan NK; Department of Pharmacy, Putrajaya Hospital, Putrajaya, Malaysia., Fong AYY; Department of Cardiology, and Clinical Research Centre, Sarawak General Hospital, Sarawak, Malaysia., Navaravong L; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, School of Medicine, Salt Lake City, Utah, USA., Hussein Z; Department of Medicine, Putrajaya Hospital, Putrajaya, Malaysia., Khunti K; Leicester Diabetes Centre, University of Leicester, Leicester, UK., Lee SWH; School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.; School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor, Malaysia.; Asian Centre for Evidence Synthesis in Population, Implementation and Clinical Outcomes (PICO), Health and Well-being Cluster, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.; Center for Global Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

المصدر: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2022 Mar; Vol. 39 (3), pp. e14780. Date of Electronic Publication: 2022 Jan 05.

نوع المنشور: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5491 (Electronic) Linking ISSN: 07423071 NLM ISO Abbreviation: Diabet Med Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*therapeutic use, Cardiovascular Diseases/mortality ; Diabetes Mellitus, Type 2/mortality ; Glucagon-Like Peptide-1 Receptor/agonists ; Humans ; Insulin/therapeutic use ; Kidney Diseases/mortality ; Metformin/therapeutic use ; Network Meta-Analysis ; Pancreatitis/mortality ; Randomized Controlled Trials as Topic ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Sulfonylurea Compounds/therapeutic use ; Thiazolidinediones/therapeutic use

المؤلفون: Loganadan NK; Department of Pharmacy, Putrajaya Hospital, Precinct 7, Putrajaya, 62250, Malaysia.; Faculty of Pharmacy, University of Malaya, Kuala Lumpur, 50603, Malaysia., Huri HZ; Faculty of Pharmacy, University of Malaya, Kuala Lumpur, 50603, Malaysia.; Clinical Investigation Centre, 5th Floor, East Tower, University of Malaya Medical Centre, Lembah Pantai, 59100, Kuala Lumpur, Malaysia., Vethakkan SR; Division of Endocrinology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia., Hussein Z; Department of Medicine, Putrajaya Hospital, Precinct 7, Putrajaya, 62250, Malaysia.

المصدر: Pharmacogenomics [Pharmacogenomics] 2021 Nov; Vol. 22 (16), pp. 1057-1068. Date of Electronic Publication: 2021 Oct 19.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacogenetics*, Diabetes Mellitus, Type 2/*genetics , Hypoglycemia/*chemically induced , Hypoglycemia/*genetics , Sulfonylurea Compounds/*adverse effects, Aged ; Blood Glucose/metabolism ; Cohort Studies ; Female ; Humans ; Hypoglycemic Agents ; Male ; Metformin ; Middle Aged ; Polymorphism, Genetic ; Prospective Studies

المؤلفون: Loganadan NK; Faculty of Pharmacy, University of Malaya, Kuala Lumpur, 50603, Malaysia., Huri HZ; Faculty of Pharmacy, University of Malaya, Kuala Lumpur, 50603, Malaysia.; Clinical Investigation Centre, 5th Floor, East Tower, University of Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, 59100, Malaysia., Vethakkan SR; Division of Endocrinology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia., Hussein Z; Department of Medicine, Putrajaya Hospital, Precinct 7, Putrajaya, 62250, Malaysia.

المصدر: Pharmacogenomics [Pharmacogenomics] 2020 Jun; Vol. 21 (9), pp. 587-600. Date of Electronic Publication: 2020 May 29.

نوع المنشور: Journal Article; Observational Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Diabetes Mellitus, Type 2/*genetics , Genetic Testing/*methods , Sulfonylurea Compounds/*therapeutic use , Sulfonylurea Receptors/*genetics, Aged ; Diabetes Mellitus, Type 2/blood ; Female ; Follow-Up Studies ; Humans ; Malaysia/epidemiology ; Male ; Middle Aged ; Predictive Value of Tests ; Prospective Studies ; Treatment Failure